Contract award notice for the provision of a suitable designated benchtop platform for Neurodegeneration Biomarker identification
Published deadline passed
The published deadline has passed. For multi-stage competitions a later tender deadline may still apply — check the notice or portal for the current phase.
Laboratorie- og analyseutstyr
St James's Hospital is planning the procurement of a suitable designated benchtop platform for Neurodegeneration Biomarker identification. Fujirebio Europe N.V. likely has the contract today.
About the bid
- Contact phone
- 01 4162468
- Contact email
- dgunning@stjames.ie
- Address
- James Street, D08 NHY1 Dublin
Following a Pre Market Consultation ( Etenders Resource ID 6396922 ) to identify suitable suppliers that can meet the Hospitals requirements it was determined that only Fujirebio Europe N.V that can meet St James’s Hospitals mandatory and desirable criteria . St James’s Hospital have a requirement to change from current (ELISA) platform for analysis of Neurodegeneration Biomarker Identification and have decided to engage with Fujirebio NV for the provision of their LUMIPULSE G600II, a chemiluminescent enzyme immunoassay (CLEIA) benchtop analyzer
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Found no award criteria in the contract notice.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- St James's Hospital
- Title
- Contract award notice for the provision of a suitable designated benchtop platform for Neurodegeneration Biomarker identification
- Type
- Main code
- Supplemental codes
- Location
- Dublin
- Estimated value
- €400,000.00
No supplemental codes from buyer…
Supplemental codes added by Cobrief